Skip to main content

Security report for pharmamar.com

PharmaMar · Healthcare · Spain

Medium risk. 4 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

71/100

Risk levelMedium

0–100, higher is better. How it is calculated

PharmaMar is a globally recognized biotechnology company specializing in the development of marine-inspired pharmaceuticals, primarily targeting cancer and virology. Established in 1998, the company has a strong market position as a leader in marine bioprospecting and drug development. Their website reflects a professional and comprehensive digital presence, targeting healthcare professionals, investors, and patients with detailed product and corporate information. The business model focuses on research, development, and commercialization of innovative drugs derived from marine organisms.

Scanned

NIS2 and GDPR posture

GDPR outside view
65/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      Third-party services without privacy policy

      Detected services: Google Analytics, Facebook, LinkedIn, YouTube, Google APIs

      What to do: Document all third-party data sharing in your privacy policy

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching pharmamar.com

This scan found 20 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
47
Security headers
65
Email security
65
DNS health
85
Network security
100
GDPR outside view
65
Average
71

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

PharmaMar operates in the healthcare sector with a focus on biotechnology and pharmaceuticals. Their competitive advantage lies in their unique marine-based drug discovery platform. The company maintains a clear and consistent brand identity and provides extensive information on products, sustainability, and investor relations. The website indicates a mature business with a large operational scale and a global reach. Partnerships and strategic alliances are hinted at but not explicitly detailed on the main site. The company targets specialized audiences including medical professionals and investors, supporting a B2B and B2C hybrid model.

Security posture

The website employs HTTPS with a good SSL configuration and standard security headers related to caching. It uses Google reCAPTCHA to protect forms and OneTrust for cookie consent, indicating awareness of privacy and security best practices. However, DNSSEC is not enabled, and additional security headers like Content-Security-Policy are absent. No incident response or security policy information is published, which could be improved. No vulnerabilities or exposed sensitive data were detected in the analysis. Overall, the security posture is solid but could benefit from enhanced header policies and published security documentation.

Recommendations

  1. Enable DNSSEC to improve domain name system security.
  2. Implement additional HTTP security headers such as Content-Security-Policy, X-Content-Type-Options, and X-Frame-Options.
  3. Publish a dedicated security policy and incident response contact information on the website.
  4. Consider establishing a vulnerability disclosure program or publishing a security.txt file.
  5. Enhance accessibility features to improve compliance and user experience for all users.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
PharmaMar
Description
Líder mundial en la exploración marina, centrada en el cáncer y la virología. Exploramos los océanos del mundo en busca de invertebrados marinos de utilidad médica.
Key services
Drug development, Marine bioprospecting, Pharmacovigilance
Content quality
excellent
Branding
consistent

Technology

Stack
WordPress, jQuery, Google Tag Manager, Google reCAPTCHA, OneTrust Cookie Consent, Slick Carousel, FontAwesome, Google Fonts
Frameworks
WordPress
Platforms
Web
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Use of Google reCAPTCHA
  • Cookie consent mechanism

Analytics and tracking

Services
Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Transparency
basic

Site quality

Design
excellent
User experience
good
Content relevance
excellent
Navigation
good
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. Content is professional and focused on biotechnology and pharmaceuticals.
  3. Strong compliance with GDPR and cookie consent regulations.
  4. Use of modern web technologies and standard security practices.
  5. No exposed sensitive data or obvious vulnerabilities detected.
  6. WHOIS data supports legitimacy and long-term business presence.
Technical notes

Notes

The website is built on WordPress CMS with a modern tech stack including jQuery, Google Tag Manager, Google reCAPTCHA, and OneTrust for cookie management. It uses external resources such as Google Fonts and FontAwesome for styling and icons. Performance is moderate with good mobile optimization and SEO practices. Accessibility is basic and could be improved. The site uses asynchronous loading for scripts and has cache control headers set to prevent stale content. Hosting provider details are not explicit. Overall, the technical infrastructure supports a professional and secure web presence with room for optimization in performance and accessibility.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with pharmamar.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review pharmamar.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.